# Sofosbuvir

## Sovaldi FC 400mg

##### 臨採

| TAH Drug Code      | [**OSOV**](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OSOV)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |
|:-------------------|:-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Chronic hepatitis C: Treatment of genotype 1, 2, 3, or 4 chronic hepatitis C (CHC) as a component of a combination antiviral treatment regimen.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| Dosing             | (仿單) 400 mg oraly once daily in combination with ribavirin or pegylated interferon + ribavirin. (Uptodate) Chronic hepatitis C (CHC) infection: Adults: Genotype 3, peginterferon + ribavirin treatment–experienced patients with compensated cirrhosis (Child-Pugh class A): 400 mg once daily with concomitant elbasvir/grazoprevir for 12 weeks. All genotypes, patients with prior glecaprevir/pibrentasvir or sofosbuvir/velpatasvir/voxilaprevir treatment failure, + or - cirrhosis (Child-Pugh class A): 400 mg once daily in combination with ribavirin and glecaprevir/pibrentasvir for 16 weeks. Children > or =3 years and Adolescents: weight < 17 kg: 150 mg once daily; 17-35 kg: 200 mg once daily; > or = 35 kg: 400 mg once daily. Treatment duration: Genotype 2: 12 weeks. Genotype 3: 24 weeks. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensivity, Pregnancy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | Fatigue, headache, nausea, insomnia & anemia. Pruritus, asthenia, rash, decreased appetite, chills, influenza-like illness, pyrexia, diarrhea, neutropenia, myalgia, irritability.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |

